×
About 8,676 results

ALLMedicine™ Prostatic Hyperplasia Center

Research & Reviews  3,453 results

MOSESTM Technology for Holmium Laser Enucleation of the Prostate: A Prospective Double-...
https://doi.org/10.1097/JU.0000000000001693
The Journal of Urology; Kavoussi NL, Nimmagadda N et. al.

Feb 22nd, 2021 - Holmium laser enucleation of the prostate (HoLEP) has proven to be efficacious and safe for the treatment of benign prostatic hyperplasia (BPH). New laser technologies, such as the MOSES™ Pulse laser system, improve energy delivery and may improve...

Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUC...
https://doi.org/10.1097/JU.0000000000001640
The Journal of Urology; Kuhlmann PK, Fischer SC et. al.

Feb 19th, 2021 - In men, complaints of nocturia causing poor sleep are often attributed to benign prostatic hyperplasia (BPH) and treated with BPH medications. We assessed whether treating lower urinary tract symptoms (LUTS) with dutasteride altered either nocturi...

Marijuana, Alcohol, and ED: Correlations with LUTS/BPH.
https://doi.org/10.1007/s11934-020-01031-9 10.1016/S0140-6736(12)61689-4 10.1111/bju.12728 10.1001/archinte.158.21.2349 10.1016/j.eururo.2008.02.019 10.1097/01.ju.0000173072.73702.64 10.1002/pros.10204 10.1016/j.ajpath.2013.11.015 10.1016/j.juro.2007.08.167 10.1016/j.urology.2010.01.069 10.1016/j.juro.2007.03.118 10.1016/j.eururo.2004.07.016 10.1002/phar.1925 10.1007/s11910-018-0814-x 10.1007/s00192-006-0086-x 10.1191/1352458504ms1063oa 10.1159/000112901 10.1016/S2215-0366(19)30401-8 10.1016/j.eururo.2010.02.027 10.1523/JNEUROSCI.22-16-07147.2002 10.1016/j.urology.2007.02.069 10.1016/j.juro.2013.10.102 10.3389/fnsys.2018.00017 10.1016/j.urology.2017.08.011 10.1016/j.urology.2018.06.054 10.1016/j.urology.2007.01.038 10.1212/WNL.0000000000000363 10.1016/S0165-0327(01)00413-X 10.1176/appi.books.9780890425596 10.4111/kju.2013.54.11.762 10.1371/journal.pone.0137903 10.4306/pi.2015.12.2.268 10.1016/j.juro.2013.03.126 10.1371/journal.pone.0217984 10.5213/inj.2015.19.2.120 10.3346/jkms.2015.30.11.1646 10.1016/j.juro.2013.12.012 10.1016/j.jad.2011.07.001 10.1371/journal.pone.0076017 10.1016/S2215-0366(17)30280-8 10.1016/S2215-0366(14)70307-4 10.1001/jamapsychiatry.2018.4500 10.1523/JNEUROSCI.4745-13.2014 10.1016/j.nbd.2009.11.020 10.1038/npp.2017.162 10.1038/535S14a 10.5173/ceju.2012.03.art7 10.1038/nrdp.2016.3 10.1016/S0022-5347(17)34871-1 10.1177/1756287213488236 10.1016/S0302-2838(03)00358-0 10.1016/j.eururo.2004.12.013 10.1016/j.urology.2008.05.034 10.1038/sj.ijir.3901371 10.1038/sj.ijir.3901425 10.1016/j.juro.2015.12.068 10.1016/j.eururo.2015.12.048 10.1016/j.ypmed.2017.07.008 10.1111/j.1743-6109.2010.02198.x 10.1016/j.pneurobio.2005.06.002 10.1016/j.eururo.2008.12.024 10.1016/j.neuropharm.2005.09.009 10.1177/1557988319892464 10.1016/j.euf.2017.11.004
Current Urology Reports; Lloyd GL, Wiesen B et. al.

Feb 8th, 2021 - Benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) is a disease complex with enormous societal burden and yet the pathogenesis of LUTS/BPH is poorly understood. We set out to review the literature on the relationship betwee...

see more →

Guidelines  7 results

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000001298
The Journal of Urology; Parsons JK, Dahm P et. al.

Jul 23rd, 2020 - The AUA Guideline panel provides evidence-based recommendations for the surgical management of male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). The Panel amended the Guideline in 2020 to reflect additional ...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1097/JU.0000000000000319
The Journal of Urology; Foster HE, Dahm P et. al.

May 6th, 2019 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference for effective evidence-based s...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hype...
https://doi.org/10.1016/j.juro.2018.05.048
The Journal of Urology; Foster HE, Barry MJ et. al.

May 18th, 2018 - Male lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is common in men and can have negative effects on quality of life (QoL). It is the hope that this Guideline becomes a reference on the effective evidence-base...

Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
http://www.auanet.org/guidelines/benign-prostatic-hyperplasia/lower-urinary-tract-symptoms-(2018)
Harris E. Foster

Apr 30th, 2018 - Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the.

Korean clinical practice guideline for benign prostatic hyperplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778754
Investigative and Clinical Urology; Yeo JK, Choi H et. al.

Mar 11th, 2016 - In 2014, the Korean Urological Association organized the Benign Prostatic Hyperplasia Guideline Developing Committee composed of experts in the field of benign prostatic hyperplasia (BPH) with the participation of the Korean Academy of Family Medi...

see more →

Drugs  789 results see all →

Clinicaltrials.gov  4,335 results

Silodosin - silodosin capsule-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2300db48-477f-4357-8de9-f723737071b4

Feb 28th, 2021 - Silodosin capsules, an alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Silodosin capsule is not indicated for the treatment of hypertension. (1) Silodosin caps...

MOSESTM Technology for Holmium Laser Enucleation of the Prostate: A Prospective Double-...
https://doi.org/10.1097/JU.0000000000001693
The Journal of Urology; Kavoussi NL, Nimmagadda N et. al.

Feb 22nd, 2021 - Holmium laser enucleation of the prostate (HoLEP) has proven to be efficacious and safe for the treatment of benign prostatic hyperplasia (BPH). New laser technologies, such as the MOSES™ Pulse laser system, improve energy delivery and may improve...

Tadalafil - tadalafil tablet, film coated-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97a42d0b-529b-f980-e053-2a95a90af682

Feb 21st, 2021 - Tadalafil is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of: • erectile dysfunction (ED) ( 1.1) • the signs and symptoms of benign prostatic hyperplasia (BPH) ( 1.2) • ED and the signs and symptoms of BPH (ED/BPH) ( 1.3) If ...

Tamsulosin hydrochloride - tamsulosin hydrochloride capsule-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=985871d9-81e2-5fda-e053-2995a90a0338

Feb 21st, 2021 - Tamsulosin hydrochloride capsules are indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) [see Clinical Studies (14)] . Tamsulosin hydrochloride capsules are not indicated for the treatment of hypertension. ...

see more →

News  79 results

Prostate Drugs Tied to Lower Risk for Parkinson's
https://www.medscape.com/viewarticle/945551

Feb 8th, 2021 - Certain drugs currently used to treat benign prostatic hyperplasia (BPH) may provide neuroprotection and delay or prevent the onset of Parkinson's disease, new research suggests. Treatment of BPH with terazosin (Hytrin), doxazosin (Cardura), or al...

Fast Five Quiz: Benign Prostatic Hyperplasia Key Aspects
https://reference.medscape.com/viewarticle/943651

Jan 11th, 2021 - Benign prostatic hyperplasia (BPH) is present in as many as 60% of men in their 60s and 90% of men older than 70 years. BPH describes nonmalignant prostate tissue growth and commonly causes lower urinary tract symptoms (LUTS). Not all men with BPH...

Urethral-sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function
https://www.staging.medscape.com/viewarticle/941123

Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...

Urethral-Sparing Robot-Assisted Simple Prostatectomy Preserves Ejaculatory Function
https://www.medscape.com/viewarticle/941123

Nov 18th, 2020 - NEW YORK (Reuters Health) - Urethral-sparing robot-assisted simple prostatectomy (usRASP) preserves ejaculatory function while relieving lower-urinary-tract symptoms (LUTS) in men with benign prostatic hyperplasia (BPH), according to findings from...

New Minimally Invasive Treatment Effective for Benign Prostatic Obstruction
https://www.medscape.com/viewarticle/937554

Sep 17th, 2020 - NEW YORK (Reuters Health) - Transperineal interstitial laser ablation (TPLA) offers another effective minimally invasive treatment for men with benign prostatic obstruction, researchers in Italy report. There are a number of minimally invasive tre...

see more →

Patient Education  13 results see all →